Business

CSL lands world-first gene therapy with $5.3m haemophilia treatment

The Aussie biotech giant will bring the first gene therapy for haemophilia B to market in the US, but the one-off treatment comes with a hefty price tag.

Business / Companies

Brisbane Times – Business

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Business